carbostyril has been researched along with Health Care Associated Infection in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (17.65) | 18.2507 |
2000's | 29 (42.65) | 29.6817 |
2010's | 23 (33.82) | 24.3611 |
2020's | 4 (5.88) | 2.80 |
Authors | Studies |
---|---|
ChaoLuMen, Q; Du, X; Lv, Y; Shi, X; Wang, J; Wang, Y; Zhang, J | 1 |
Han, X; Hu, H; Jiang, Y; Liao, W; Meng, Y; Quan, J; Shi, Q; Wang, Q; Yu, Y; Zhang, H; Zhao, D; Zhou, J | 1 |
Khairy, RMM; Kotb, DN; Mahdy, WK; Mahmoud, MS | 1 |
El Salam, MA; Faried, OA; Zaki, MES | 1 |
Aouni, M; Ben Jeddou, A; Bouallegue, O; Boujaafar, N; Charfi, K; Grami, R; Mammeri, H; Mani, Y; Mansour, W; Messaoudi, A | 1 |
Ehara, T; Haque, A; Huda, Q; Matsumoto, T; Miah, RA; Ohkusu, K; Okanda, T | 1 |
Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
Gutiérrez-Gutiérrez, B; López-Cerero, L; Morales Barroso, I; Navarro, MD; Pascual, A; Rodríguez-Baño, J | 1 |
Balfour-Lynn, IM | 1 |
Chen, ZH; Dai, XT; Feng, W; Luo, GM; Sun, FJ; Xia, PY; Xiong, W | 1 |
Arpi, M; Boel, JB; Bøggild, N; Gjørup, I; Hansen, SW; Jarløv, JO | 1 |
Huang, S; Pu, S; Sun, J; Xu, X; Yang, S; Zhang, C; Zhang, L | 1 |
Centelles, MJ; Gentille, D; Pérez, M | 1 |
Bulanda, M; Chmielarczyk, A; de Champs, C; Guillard, T; Heczko, PB; Pobiega, M; Rozanska, A; Wojkowska-Mach, J | 1 |
Baker, S; Campbell, JI; Cerdeno-Tarraga, A; Le, V; Nhu, NTK; Nhu, TDH; Schultsz, C; Tam, PTT; Thomson, NR; Thwaites, G; Tuyen, HT | 1 |
Giske, CG; Iversen, A; Nematzadeh, S; Shahcheraghi, F | 1 |
Chang, Y; Deng, S; Jia, X; Ling, B; Luan, G; Shen, M; Wang, Y; Yang, J; Zhang, C | 1 |
Betts, J; Liakopoulos, A; Mevius, D; Oikonomou, O; Phee, LM; Wareham, DW | 1 |
Mondal, A; Rajamohan, G; Srinivasan, VB; Venkataramaiah, M | 1 |
Alberg, T; Blix, HS; Eriksen, HM; Holen, Ø; Neteland, MI; Smith, I | 1 |
Pitiriga, V; Saroglou, G; Tsakris, A; Vrioni, G | 1 |
Catrou, PG; Cook, PP; Das, TD; Gooch, M | 1 |
Cambau, E; Corbel, C; Lascols, C; Liassine, N; Soussy, CJ; Zulueta-Rodriguez, P | 1 |
Alquezar, A; Castro, P; Codina, C; Delgado, E; Marco, F; Martí, S; Martínez, JA; Mensa, J; Nicolás, JM; Soriano, A; Torres, A; Trilla, A; Vila, J | 1 |
Appelbaum, PC; Bhagwat, SS; Kosowska-Shick, K; McGhee, P; Patel, MV | 1 |
Anguel, N; Carrër, A; Fortineau, N; Lassel, L; Mansouri, M; Nordmann, P; Richard, C | 1 |
Amin, AK; Wareham, DW | 1 |
Bernabeu, S; Monnet, X; Nordmann, P; Poirel, L; Potron, A; Richard, C | 1 |
Levin, AS | 1 |
Bouallègue, O; Dahmen, S; Mansour, W; Nordmann, P; Poirel, L | 1 |
Ahn, SB; Byun, TJ; Cho, HS; Eun, CS; Han, DS; Jeon, YC; Kang, JO; Kim, TY; Sohn, JH | 1 |
Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C | 1 |
Cheek, E; Citron, DM; Cubbon, M; Gerding, DN; Lippett, S; Llewelyn, M; Price, J; Sambol, SP | 1 |
Fujita, M; Ishikura, H; Kitamura, T; Matsumoto, T; Toyoshima, H; Watanabe, K; Yoshimura, C | 1 |
De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M | 1 |
Khawcharoenporn, T; Singh, K; Vasoo, S; Ward, E | 1 |
Cai, JC; Chen, GX; Hu, YY; Sun, Q; Zhang, R; Zhou, HW | 1 |
Lowy, FD | 1 |
Di, JH; Shen, XZ; Yang, YH | 1 |
Naber, KG | 1 |
Biehler, K; Daschner, FD; Hartung, D; Jonas, D; Spitzmüller, B | 1 |
Kollef, MH; Shorr, AF; Susla, GB | 1 |
Aihara, M; Higuchi, T; Kinoshita, S; Kofuku, T; Komatsu, M; Nishio, H; Orita, T; Sakamoto, M; Satoh, K; Shimakawa, K; Sueyoshi, N; Toyokawa, M; Wada, Y; Yamasaki, K; Yamashita, T | 1 |
Mirelis, B; Prats, G; Rossi, V; Salvatori, E | 1 |
Carmeli, Y; Dodds, AE; Engemann, JJ; Kanafani, ZA; Kaye, KS; Weber, SG | 1 |
Akanbi, AA; Fadeyi, A; Nwabuisi, C; Onile, BA | 1 |
Bonten, MJ; Leavis, HL; Willems, RJ | 1 |
Bonomo, RA; Szabo, D | 1 |
De Champs, C; Eloy, C; Nordmann, P; Poirel, L | 1 |
Diekema, DJ; Doebbeling, BN; Ernst, EJ; Sutherland, JM; Vaughn, TE; Wilson, SJ; Zillich, AJ | 1 |
Chiba, M; Dohmae, S; Fujikawa, K; Otsuka, T; Saito, K; Takano, T; Tanaka, M; Yamamoto, T | 1 |
Chang, MT; Huang, CY; Jang, TN; Wang, CY; Wu, TH | 1 |
Hiramatsu, K; Ito, T; Watanabe, S | 1 |
Hansen, DS; Skov, RL; Urth, TR | 1 |
Ammari, H; Arlet, G; Bakour, R; Iabadene, H; Lounes, S; Messai, Y; Ramdani-Bouguessa, N | 1 |
Matuschka, PR; Vissing, RS | 1 |
Claus, H; Cuny, C; Witte, W | 1 |
Amaral, JL; Hollis, R; Jones, RN; Leme, IL; Pfaller, MA; Pignatari, A; Rodrigues, JN; Wey, S | 1 |
Molinari, G; Schito, GC | 1 |
Lochmann, O; Vyhnánek, F | 1 |
Cluzel, M; Dabernat, H; Derlot, E; Exmelin, L; Kitzis, MD; Le Noc, P; Muller-Serieys, C; Reverdy, ME; Scheftel, JM; Soussy, CJ; Thabaut, A | 1 |
Ageron, E; Bollet, C; Bosi, C; Charrel, R; Cremieux, A; Davin-Regli, A; Grimont, PA; Papazian, L | 1 |
Mingoia, M; Montanari, MP; Varaldo, PE | 1 |
Watanabe, A | 1 |
Benz-Lemoine, E; Castel, O; Delwail, V; Giraud, C; Grollier, G; Guilhot, F; Robert, R; Roblot-Casenave, F; Tanzer, J | 1 |
Goto, T; Mizuma, Y; Ohi, Y | 1 |
Bergogne-Berezin, E; Joly-Guillou, ML; Vieu, JF | 1 |
Kanno, H | 1 |
11 review(s) available for carbostyril and Health Care Associated Infection
Article | Year |
---|---|
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Clinical papers of the year 2018 - Cystic fibrosis.
Topics: Administration, Inhalation; Aminophenols; Aminopyridines; Anti-Bacterial Agents; Azithromycin; Benzodioxoles; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Chloride Channel Agonists; Cough; Cross Infection; Cystic Fibrosis; Disease Progression; Drug Combinations; Drug Therapy, Combination; Humans; Indoles; Lung Transplantation; Microbiological Techniques; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Nebulizers and Vaporizers; Proton Pump Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Randomized Controlled Trials as Topic; Saline Solution, Hypertonic; Specimen Handling; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
The Impact of Antibiotic Stewardship Programs in Combating Quinolone Resistance: A Systematic Review and Recommendations for More Efficient Interventions.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Clostridioides difficile; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Practice Guidelines as Topic; Prospective Studies; Quinolones | 2017 |
Nosocomial legionellosis: prevention and management.
Topics: Anti-Infective Agents; Cross Infection; Humans; Infection Control; Legionella pneumophila; Legionellosis; Macrolides; Primary Prevention; Quinolones; Water Microbiology; Water Supply | 2009 |
Antimicrobial resistance: the example of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Penicillins; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
[Progresses in molecular biologic studies on coagulase negative staphylococcus infection].
Topics: Bacteremia; Catheterization; Child; Coagulase; Cross Infection; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Methicillin; Quinolones; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections; Vancomycin | 2004 |
Levofloxacin in the treatment of urinary tract infections and prostatitis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Female; Fluoroquinolones; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prostatitis; Quinolones; Severity of Illness Index; Treatment Outcome; Urinary Tract Infections | 2004 |
Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic | 2005 |
Prulifloxacin: a new antibacterial fluoroquinolone.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Piperazines; Quinolones; Respiratory Tract Infections; Treatment Outcome | 2006 |
Identification of high-risk enterococcal clonal complexes: global dispersion and antibiotic resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Biological Evolution; Cross Infection; Disease Outbreaks; Drug Resistance; Drug Resistance, Bacterial; Enterococcus faecium; Europe; Genes, Bacterial; Genomic Islands; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Quinolones; United States; Virulence | 2006 |
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
Topics: Acinetobacter; Aminoglycosides; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Porins; Pseudomonas aeruginosa; Quinolones | 2006 |
2 trial(s) available for carbostyril and Health Care Associated Infection
Article | Year |
---|---|
The impact of an intensive antimicrobial control program in a Taiwanese medical center.
Topics: Adult; Aged; Aminoglycosides; Anti-Infective Agents; Bacterial Infections; Cephalosporins; Cross Infection; Drug Costs; Drug Resistance, Bacterial; Drug Utilization Review; Economics, Hospital; Erythromycin; Female; Glycopeptides; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Quinolones; Taiwan; Tetracyclines; Time Factors; Treatment Outcome | 2006 |
Clinafloxacin-theophylline drug interaction.
Topics: Aged; Anti-Infective Agents; Cross Infection; Delayed-Action Preparations; Drug Interactions; Drug Monitoring; Fluoroquinolones; Humans; Lung Diseases, Obstructive; Male; Pneumonia; Quinolones; Theophylline | 1995 |
55 other study(ies) available for carbostyril and Health Care Associated Infection
Article | Year |
---|---|
Wide spread and diversity of mutation in the gyrA gene of quinolone-resistant Corynebacterium striatum strains isolated from three tertiary hospitals in China.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Cross Infection; DNA Gyrase; Drug Resistance, Multiple; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Quinolones; Tertiary Care Centers | 2021 |
Investigating Possible Interspecies Communication of Plasmids Associated with Transfer of Third-Generation Cephalosporin, Quinolone, and Colistin Resistance Between Simultaneously Isolated Escherichia Coli and Klebsiella Pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Coinfection; Colistin; Communication; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones | 2023 |
Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Plasmids; Quinolones; Urinary Tract Infections; Young Adult | 2019 |
Study of Plasmid-Mediated Quinolone Resistance in Escherichia coli from Nosocomial Urinary Tract Infections.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Plasmids; Quinolones; Urinary Tract Infections | 2021 |
Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates from neonates in Tunisia.
Topics: Bacterial Proteins; beta-Lactamases; Citrobacter freundii; Cross Infection; Disease Transmission, Infectious; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Genotype; Humans; Infant, Newborn; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; Retrospective Studies; Tertiary Care Centers; Tunisia | 2017 |
Characteristics of Resistance Mechanisms and Molecular Epidemiology of Fluoroquinolone-Nonsusceptible
Topics: Anti-Bacterial Agents; Bangladesh; Cross Infection; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Mutation; Quinolones; Salmonella enterica; Salmonella Infections; Salmonella paratyphi A; Tertiary Care Centers; Typhoid Fever | 2018 |
Intestinal colonization due to
Topics: Adult; Aged; Anti-Infective Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Family Characteristics; Feces; Female; Humans; Male; Middle Aged; Prevalence; Quinolones; Rectum; Risk Factors | 2018 |
The epidemiology and resistance mechanisms of Acinetobacter baumannii isolates from the respiratory department ICU of a hospital in China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Child, Preschool; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Infant; Infant, Newborn; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Quinolones; Young Adult | 2014 |
[Antibiotic stewardship has been established at Herlev Hospital].
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Clostridium Infections; Cross Infection; Drug Prescriptions; Drug Utilization Review; Hospitals; Humans; Medical Audit; Practice Guidelines as Topic; Practice Patterns, Physicians'; Quinolones | 2014 |
Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Genotype; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Phenotype; Prevalence; Quinolones | 2014 |
[Bacteremia by a Serratia rubidaea with an atypical quinolones resistance phenotype].
Topics: Adolescent; Bacteremia; Cross Infection; Humans; Male; Microbial Sensitivity Tests; Phenotype; Quinolones; Serratia; Serratia Infections | 2014 |
The High Prevalence of Plasmid-Mediated Quinolone Resistance Among Very Low Birth-Weight Infants in Poland.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Plasmids; Poland; Prevalence; Public Health Surveillance; Quinolones | 2015 |
Genetic characterization of three qnrS1-harbouring multidrug-resistance plasmids and qnrS1-containing transposons circulating in Ho Chi Minh City, Vietnam.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Interspersed Repetitive Sequences; Molecular Sequence Data; Plasmids; Quinolones; Sequence Analysis, DNA; Vietnam | 2015 |
Successful international clones of blaCTX-M-15-producing Klebsiella pneumoniae with coexpression of plasmid-mediated quinolone resistance (PMQR) determinants in Tehran hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Molecular Typing; Plasmids; Quinolones | 2015 |
Coexistence of blaOXA-23 with armA in quinolone-resistant Acinetobacter baumannii from a Chinese university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; China; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Phylogeny; Quinolones | 2016 |
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Gene Expression; Gene Transfer, Horizontal; Greece; Humans; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Plasmids; Providencia; Quinolones; Replicon; Survival Analysis | 2016 |
Occurrence of Diverse Antimicrobial Resistance Determinants in Genetically Unrelated Biocide Tolerant Klebsiella pneumoniae.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Quinolones | 2016 |
Broad-spectrum antibiotics in Norwegian hospitals.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization Review; Guideline Adherence; Hospitals; Humans; Norway; Piperacillin; Quinolones; Respiratory Tract Infections | 2017 |
Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
Topics: Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Incidence; Microbial Sensitivity Tests; Program Evaluation; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 2008 |
First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Male; Plasmids; Quinolones; Switzerland | 2008 |
Influence of antipseudomonal agents on Pseudomonas aeruginosa colonization and acquisition of resistance in critically ill medical patients.
Topics: Adult; Cephalosporins; Critical Illness; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genes, Viral; Genotype; Humans; Intensive Care Units; Male; Pharynx; Piperacillin; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Rectum; Respiratory Mucosa | 2009 |
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin Resistance | 2009 |
Outbreak of CTX-M-15-producing Klebsiella pneumoniae in the intensive care unit of a French hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Microbial Sensitivity Tests; Plasmids; Quinolones; Rectum; Reverse Transcriptase Polymerase Chain Reaction | 2009 |
Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; London; Microbial Sensitivity Tests; Plasmids; Quinolones; Urinary Tract Infections | 2009 |
Nosocomial spread of ESBL-positive Enterobacter cloacae co-expressing plasmid-mediated quinolone resistance Qnr determinants in one hospital in France.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; France; Genes, Bacterial; Hospitals; Humans; Plasmids; Quinolones | 2009 |
Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Integrons; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Tunisia | 2010 |
[Clinical characteristics and changing epidemiology of Clostridium difficile-associated disease (CDAD)].
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacterial Toxins; Cephalosporins; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Enterotoxins; Female; Humans; Male; Metronidazole; Middle Aged; Quinolones; Retrospective Studies | 2009 |
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela | 2008 |
Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Doxycycline; Drug Utilization; Health Services Research; Hospitals; Humans; Infection Control; Organizational Policy; Prevalence; Quinolones | 2010 |
[A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones | 2010 |
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome | 2011 |
High rates of quinolone resistance among urinary tract infections in the ED.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Emergency Service, Hospital; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Quinolones; Retrospective Studies; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2012 |
Emergence of Proteus mirabilis harboring blaKPC-2 and qnrD in a Chinese Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Ciprofloxacin; Clone Cells; Conjugation, Genetic; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2012 |
Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units.
Topics: Anti-Bacterial Agents; Bacteria; Citrobacter freundii; Cross Infection; Drug Resistance, Bacterial; Enterobacter; Germany; Humans; Integrons; Intensive Care Units; Microbial Sensitivity Tests; Plasmids; Quinolones; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
In vitro activity of beta-lactams and quinolones against AmpC beta-lactamase-producing Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefazolin; Cross Infection; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Japan; Microbial Sensitivity Tests; Quinolones | 2005 |
Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosa.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Case-Control Studies; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Levofloxacin; Male; Middle Aged; Ofloxacin; Pseudomonas Infections; Quinolones; Regression Analysis; Retrospective Studies; Risk Factors | 2006 |
Antibiotic disc sensitivity pattern of pseudomonas aeruginosa isolates obtained from clinical specimens in Ilorin, Nigeria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Nigeria; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones | 2005 |
Nosocomial spread of QnrA-mediated quinolone resistance in Enterobacter sakazakii.
Topics: Cronobacter sakazakii; Cross Infection; Drug Resistance, Bacterial; Humans; Polymerase Chain Reaction; Quinolones | 2007 |
Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals.
Topics: Anti-Bacterial Agents; Ceftazidime; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterococcus; Escherichia coli; Hospital Bed Capacity; Hospitals, Veterans; Humans; Information Dissemination; Klebsiella; Methicillin Resistance; Practice Guidelines as Topic; Quinolones; Surveys and Questionnaires; United States; Vancomycin Resistance | 2006 |
Molecular characteristics and in vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of Panton-Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus isolates from the community and hospitals.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Exotoxins; Fluoroquinolones; Hospitals; Humans; Leukocidins; Methicillin Resistance; Microbial Sensitivity Tests; Pyrrolidines; Quinolones; Rifampin; Staphylococcus aureus | 2006 |
Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619.
Topics: Anti-Infective Agents; Bacterial Proteins; Coagulase; Community-Acquired Infections; Cross Infection; DNA Gyrase; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pyrrolidines; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2007 |
[Methicillin resistant S. aureus and multi-resistant Enterobacteriaceae. Two of the most significant resistance problems in Denmark].
Topics: beta-Lactam Resistance; Cross Infection; Denmark; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Infection Control; Methicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria.
Topics: Algeria; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA | 2008 |
Unrelatedness of multiply resistant Staphylococcus aureus with resistance to methicillin and to quinolones (QR-MRSA) as evident from SmaI-digestion patterns of genomic DNA.
Topics: Bacterial Typing Techniques; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Genome, Bacterial; Humans; Methicillin Resistance; Mutation; Polymorphism, Restriction Fragment Length; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 1993 |
Molecular epidemiology and antimicrobial susceptibility testing. Testing of quinolone-resistant Staphylococcus aureus strains isolated in Brazil.
Topics: Bacteriophage Typing; Brazil; Carrier State; Cephalosporins; Cross Infection; Disease Outbreaks; DNA Restriction Enzymes; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Staphylococcal Infections; Staphylococcus aureus | 1993 |
Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1995 |
[Fluoroquinolones in antimicrobial therapy and prophylaxis in surgery].
Topics: 4-Quinolones; Anti-Infective Agents; Ceftazidime; Cross Infection; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pefloxacin; Pneumonia, Bacterial; Postoperative Complications; Premedication; Quinolones; Wounds and Injuries | 1995 |
[In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve].
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Cross Infection; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Quinolones; Regression Analysis | 1996 |
A nosocomial outbreak due to Enterobacter cloacae strains with the E. hormaechei genotype in patients treated with fluoroquinolones.
Topics: Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; France; Humans; Quinolones | 1997 |
In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates.
Topics: Anti-Infective Agents; Community-Acquired Infections; Cross Infection; Dioxolanes; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Italy; Microbial Sensitivity Tests; Piperazines; Quinolones | 2001 |
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |
Nosocomial legionnaires' disease in a bone marrow transplant unit.
Topics: Adult; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Cross Infection; Female; Fluorescent Antibody Technique; Humans; Legionella; Legionnaires' Disease; Male; Quinolones; Temperature | 1991 |
[Urinary tract infections caused by Pseudomonas aeruginosa].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Humans; Lactams; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Urinary Tract Infections | 1991 |
[Epidemiology of Acinetobacter and resistance to antibiotics at hospitals. A 5-year evaluation].
Topics: Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Humans; Lactams; Phenotype; Quinolones | 1990 |
[Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Disinfectants; Humans; Lactams; Macrolides; Methicillin Resistance; Postoperative Complications; Quinolones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines; Vancomycin | 1990 |